Gary Lieskovsky

Urology
1441 Eastlake Ave Ste 7416
Los Angeles, CA 90089

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients.

Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2023

Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study.

Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study.

Journal: World journal of urology
Published: July 23, 2017

Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases.

Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases.

Journal: The Prostate
Published: August 20, 2016

Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era.

Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: February 10, 2016

Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era.

Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era.

Journal: Urologic oncology
Published: February 09, 2013

Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.

Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.

Journal: Urologic oncology
Published: May 03, 2012

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.

Journal: Urologic oncology
Published: January 22, 2012

Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.

Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.

Journal: European urology
Published: January 22, 2012

Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.

Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.

Journal: Urologic oncology
Published: January 03, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026